New honour for Gates Cambridge Provost

  • May 7, 2014
New honour for Gates Cambridge Provost

The Provost of the Gates Cambridge Trust, Professor Barry Everitt, is among 106 outstanding researchers to be elected as a member of one of the most prestigious life sciences organisations in Europe this week.

The Provost of the Gates Cambridge Trust, Professor Barry Everitt, is among 106 outstanding researchers to be elected as a member of one of the most prestigious life sciences organisations in Europe this week.

It is the first time that neuroscientists in general and behavioural neuroscientists in particular, have been elected to EMBO. The organisation is made up of  more than 1,500 leading researchers and promotes excellence in the life sciences. Its major goals are to support talented researchers at all stages of their careers, stimulate the exchange of scientific information and help build a European research environment where scientists can achieve their best work.

EMBO says it has decided to strategically expand the scope of its membership on the occasion of its 50th anniversary to honour the progress that has been made in the fields of neuroscience and ecology & evolution. Fifty of the 106 new members are scientists who have made “exceptional contributions” in these areas.

“For the 50th anniversary of EMBO we are extremely pleased to welcome significantly more researchers to our membership than in previous years,” EMBO Director Maria Leptin said. “In the past decades, many of the concepts, techniques and insights of molecular biology have been applied to fundamental questions in other disciplines of the life sciences. Molecular explanations are now emerging for the origins and functions of complex systems like the brain and the living world around us. We wanted to reflect more of these exciting developments in our membership.”

Leptin added: “Great leaps in scientific progress often arise when fundamental approaches like molecular biology are applied to previously unconsidered or emerging disciplines. Looking forward, we want to ensure that all communities of the life sciences benefit from this type of cross-pollination.”

EMBO members provide suggestions and feedback on the activities of EMBO, serve on selection committees for EMBO programmes and mentor young scientists.

Professor Everitt’s research, which has won him many awards, including most recently the prestigious Fondation Ipsen prize,  is in the general area of behavioural neuroscience and is concerned with the neural and psychological mechanisms underlying learning, memory and motivation. His major research focus is the neuropsychology of drug addiction. He has been President of the British Association for Psychopharmacology, the European Brain and Behaviour Society and the European Behavioural Pharmacology Society. He served as Editor-in-Chief of the European Journal of Neuroscience and is currently a reviewing editor for Science.

Latest News

Olympic opening ceremony harks back to tradition of ‘liquid streets’

The opening ceremony of the 2024 Olympic Games today will see athletes from around the world cross the centre of Paris on boats, navigating the waters of the river Seine, using it and its banks as life-size stages. Although the ceremony is being billed as innovative, it is in fact part of a centuries-old tradition […]

Why AI needs to be inclusive

When Hannah Claus [2024] studied computer science at school she soon realised that she was in a room full of white boys, looking at posters of white men. “I could not see myself in that,” she says. “I realised there were no role models to follow and that I had to become that myself. There […]

New book deal for Gates Cambridge Scholar

A Gates Cambridge Scholar has signed a deal to write a book on Indigenous climate justice. The Longest Night will be published by Atria Books, part of Simon & Schuster, and was selected as the deal of the day by Publishers Marketplace earlier this week. Described as “a stunning exploration of the High North and […]

Why understanding risk for different populations can reduce cardiovascular deaths

The incidence of cardiovascular disease (CVD) – the number one cause of death globally – can be reduced significantly by understanding the risk faced by different populations better, according to a new study. Identifying individuals at high risk and intervening to reduce risk before an event occurs underpins the majority of national and international primary […]